Opinion
Video
Author(s):
The expert panel concludes their discussion with a look toward the future of prostate cancer treatment and the evolving role of rectal spacers.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025
Phase 1 study launches for novel CYP11A1 inhibitor for mCRPC
Dr. Murphy on increasing diversity in cancer clinical trials
GLP-1 agonist use is rising in men with prostate cancer
ARANOTE: Darolutamide improves HRQoL in mHSPC
FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
PSMA-PET imaging product, Gozellix, launches on US market
Adding cetrelimab to niraparib maintenance shows benefit in aggressive variant prostate cancer